(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the ...

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

Carlos Doti has moved countries and changed jobs, but one thing hasn’t changed. Making an impact on patient care has always ...

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

The FDA’s reviewers pointed out that Stealth’s elamipretide missed its primary efficacy endpoints in the main study used to ...

In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational ...

The rejection is related to the timing of the FDA’s reinspection of Zealand’s third-party manufacturer, which previously had ...

Managers face a variety of challenges during their careers. Instead of falling into fight or flight, develop resilience to ...